Total Health's 2023 ASCO Direct™ India Conference is an officially licensed Best of ASCO meeting. This Post ASCO Review will showcase abstracts from highly rated presentations, allowing attendees to engage with the latest research and strategies in oncology education. This accredited meeting will be hosted as an hybrid conference, featuring in-person attendance with virtual and on-demand access for registered attendees.
Register free to join us in person in Hyderabad, India or virtually on Friday and Saturday, August 11-12, 2023.
Learning Objectives
-
Employ an understanding of personalized medicine to individualize the use of available drugs for breast, GI, GU, lung, and hematological cancers.
-
Communicate the efficacy and safety of the drugs discussed in the case studies and other emerging treatments for breast, GI, GU, lung, and hematological cancers.
-
Understand the emerging and standard diagnostic tests used to assist in planning therapy for breast, GI, GU, lung, and hematological cancers.
-
Formulate management strategies, considering the contributory roles of local and systemic therapy.
-
Recall the design of ongoing clinical trials evaluating novel investigational agents and counsel appropriately selected patients about availability and participation.
Accreditation Information | TBD
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of TBD ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of TBD AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of TBD knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
​
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to TBD Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 30 days of the activity to meet the deadline for submission to PARS.
Learning Objectives
-
Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.
-
Implement practice changes in a variety of treatment options for solid tumors, including lung, breast, melanoma, colorectal, non-colorectal GI, and GU cancers.
-
Stimulate innovative strategies for new and additional research related to treatment and prevention.
-
Recognize the implications for practice change in both the academic and community practice settings.
What to Expect
In-Person Learners
-
Free registration for all healthcare providers
-
Expert sessions that present the most clinically relevant data, research, and clinical strategies
-
Enduring video content for watching at your leisure
-
Real-time discussion and debate
-
Networking with peers, colleagues, and medical professionals
-
Access to the latest industry information and resources
-
Catered meals through-out the program
-
Special in-person networking reception, catered and open bar